Clincosm LogoSign in Get a demo

Multiple Myeloma

Showing 126 - 150 of 1,882
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Adult B-Cell, Chronic Lymphocytic Leukemia, Multiple Myeloma Trial in United States (clonoSEQ

Recruiting
  • Acute Lymphoblastic Leukemia, Adult B-Cell
  • +3 more
  • clonoSEQ Assay
  • Stanford, California
  • +15 more
Jan 30, 2023

Samples and Clinical Data From Patients With Amyloid Diseases

Recruiting
  • Multiple Myeloma
  • clonality analysis
  • +6 more
  • Boston, Massachusetts
    Boston University Cancer Research Center
Jan 28, 2023

Multiple Myeloma Trial in Worldwide (Talquetamab, Teclistamab, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +12 more
Jan 27, 2023

Multiple Myeloma Trial in Beijing, Suzhou (CAR-BCMA T Cells)

Recruiting
  • Multiple Myeloma
  • CAR-BCMA T Cells
  • Beijing, Beijing, China
  • +1 more
Jan 26, 2023

Multiple Myeloma Trial in Worldwide (Bortezomib, Dexamethasone, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • San Francisco, California
  • +152 more
Jan 27, 2023

Multiple Myeloma Trial in Worldwide (Teclistamab, Daratumumab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Tucson, Arizona
  • +189 more
Jan 27, 2023

Multiple Myeloma Trial in Spain, United States (BB2121, CC-220, BMS-986405)

Recruiting
  • Multiple Myeloma
  • BB2121
  • +2 more
  • Birmingham, Alabama
  • +33 more
Jan 26, 2023

Multiple Myeloma Trial in Boston, Columbus (drug, biological, other)

Terminated
  • Multiple Myeloma
  • Boston, Massachusetts
  • +1 more
Nov 14, 2022

Multiple Myeloma Trial (Continued treatment adapted to the response)

Completed
  • Multiple Myeloma
  • Continued treatment adapted to the response
  • (no location specified)
Jan 14, 2023

Solid Tumors, Adult, Multiple Myeloma, Lymphoma Trial in San Antonio (VP301)

Recruiting
  • Solid Tumors, Adult
  • +2 more
  • San Antonio, Texas
    NEXT Oncology
Jan 16, 2023

Multiple Myeloma Trial in Houston (Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A))

Not yet recruiting
  • Multiple Myeloma
  • Fully human BCMA chimeric antigen receptor autologous T cell injection (CT103A)
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jan 13, 2023

Multiple Myeloma Trial in United States (Lenalidomide, Daratumumab/rHuPH20)

Recruiting
  • Multiple Myeloma
  • Anchorage, Alaska
  • +698 more
Jan 24, 2023

Hematologic Malignancy, Blood Cancer, Lymphoma Trial in Boston (Palliative Care, Usual Care)

Recruiting
  • Hematologic Malignancy
  • +4 more
  • Palliative Care
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 24, 2023

Multiple Myeloma Trial in Boston (Health Through Activity)

Not yet recruiting
  • Multiple Myeloma
  • Health Through Activity
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jan 17, 2023

Multiple Myeloma Trial in Charlotte (Elotuzumab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Charlotte, North Carolina
    Levine Cancer Institute
Jan 24, 2023

Multiple Myeloma Trial in West Hollywood, Cary (Selinexor, Placebo (for selinexor), carfilzomib)

Withdrawn
  • Multiple Myeloma
  • West Hollywood, California
  • +1 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Elranatamab, Lenalidomide)

Recruiting
  • Multiple Myeloma
  • Benowa, Queensland, Australia
  • +132 more
Jan 24, 2023

Multiple Myeloma Trial in Worldwide (Selinexor, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Birmingham, Alabama
  • +60 more
Jan 24, 2023

Agricultural Health Study Cohort Pesticide Exposure Study

Completed
  • Multiple Myeloma
  • +3 more
    • Iowa City, Iowa
    • +1 more
    Jan 25, 2023

    Multiple Myeloma Trial in Germany (Teclistamab (Tec), Daratumumab, Dexamethasone)

    Recruiting
    • Multiple Myeloma
    • Teclistamab (Tec)
    • +4 more
    • Berlin, Germany
    • +8 more
    Jan 19, 2023

    Multiple Myeloma, AL Amyloidosis Trial in New York (Siltuximab, The M.D. Anderson Symptom Inventory (MDASI))

    Active, not recruiting
    • Multiple Myeloma
    • AL Amyloidosis
    • Siltuximab
    • The M.D. Anderson Symptom Inventory (MDASI)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Multiple Myeloma Trial in Worldwide (Modakafusp Alfa, Daratumumab)

    Recruiting
    • Multiple Myeloma
    • Gilbert, Arizona
    • +40 more
    Jan 23, 2023

    Multiple Myeloma Trial in United States (Pomalidomide, stem cell, Dexamethasone)

    Active, not recruiting
    • Multiple Myeloma
    • Basking Ridge, New Jersey
    • +9 more
    Jan 23, 2023

    Taste Function In Multiple Myeloma Patients Undergoing

    Active, not recruiting
    • Multiple Myeloma
    • Oral microbiota assessment
    • +3 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023

    Leukemia, Multiple Myeloma, Myelodysplastic Syndrome Trial in New York (biological, procedure, radiation, drug)

    Active, not recruiting
    • Leukemia
    • +3 more
    • Palifermin
    • +6 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Jan 23, 2023